Ziyuglycoside II Inhibits the Growth of Human Breast Carcinoma MDA-MB-435 Cells via Cell Cycle Arrest and Induction of Apoptosis through the Mitochondria Dependent Pathway

被引:41
作者
Zhu, Xue [1 ]
Wang, Ke [1 ]
Zhang, Kai [1 ]
Huang, Biao [1 ]
Zhang, Jue [1 ]
Zhang, Yi [1 ]
Zhu, Lan [1 ]
Zhou, Bin [1 ]
Zhou, Fanfan [2 ]
机构
[1] Jiangsu Inst Nucl Med, Key Lab Nucl Med, Jiangsu Key Lab Mol Nucl Med, Minist Hlth, Wuxi 214063, Peoples R China
[2] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia
关键词
ziyuglycoside II; MDA-MB-435; cell cycle arrest; cell apoptosis; CYTOCHROME-C; G2/M ARREST; CANCER; P53; EXTRACT; TRASTUZUMAB; ACTIVATION; ANTITUMOR; AGENT; ROOT;
D O I
10.3390/ijms140918041
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ziyuglycoside II is one of the major active compounds of Sanguisorba officinalis L., which has a wide range of clinical applications including hemostasis, antibiosis, anti-inflammation and anti-oxidation. This study investigated the effect of ziyuglycoside II on the growth of human breast carcinoma MDA-MB-435 cells for the first time. The results showed that ziyuglycoside II could significantly inhibit the growth of MDA-MB-435 cells through blocking cell cycle progression at G0/G1 and S phase as well as via inducing cell apoptosis. Accumulation of reactive oxygen species (ROS) was observed in the progression of cell cycle arrest, which was associated with the increased expression of cell cycle regulating factors, p53 and p21. Subsequent apoptosis induced by ziyuglycoside II was accompanied with the activation of mitochondrial pathway, in particular a decreased mitochondrial membrane potential (MMP) as well as increased Bax/Bcl-2 ratio, cytochrome c release and the activity of caspase-3 and caspase-9. In conclusion, our study was the first to report that ziyuglycoside II has inhibitory effect on the growth of MDA-MB-435 cells, which might become a potential therapeutic approach of breast cancer in the future.
引用
收藏
页码:18041 / 18055
页数:15
相关论文
共 38 条
[1]   Towards an understanding of breast cancer etiology [J].
Adami, HO ;
Signorello, LB ;
Trichopoulos, D .
SEMINARS IN CANCER BIOLOGY, 1998, 8 (04) :255-262
[2]   Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells [J].
Aoudjit, F ;
Vuori, K .
ONCOGENE, 2001, 20 (36) :4995-5004
[3]  
Bang YJ, 2010, LANCET, V376, P1302
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]   Anti-tumor and immunomodulating activities of a polysaccharide from the root of Sanguisorba officinalis L. [J].
Cai, Zibin ;
Li, Wei ;
Wang, Haotian ;
Yan, Weiqun ;
Zhou, Yulai ;
Wang, Guanjun ;
Cui, Jiuwei ;
Wang, Fang .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2012, 51 (04) :484-488
[6]   MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma? [J].
Chambers, Ann F. .
CANCER RESEARCH, 2009, 69 (13) :5292-5293
[7]   Methanol extract of Sanguisorba officinalis L. with cytotoxic activity against PC3 human prostate cancer cells [J].
Choi, Eun-Sun ;
Kim, Jun-Sung ;
Kwon, Ki-Han ;
Kim, Hyng-Seop ;
Cho, Nam-Pyo ;
Cho, Sung-Dae .
MOLECULAR MEDICINE REPORTS, 2012, 6 (03) :670-674
[8]   Caspase family proteases and apoptosis [J].
Fan, TJ ;
Han, LH ;
Cong, RS ;
Liang, J .
ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2005, 37 (11) :719-727
[9]  
FREEMAN BA, 1982, LAB INVEST, V47, P412
[10]   Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models [J].
Fujimoto-Ouchi, Kaori ;
Sekiguchi, Fumiko ;
Yasuno, Hideyuki ;
Moriya, Yoichiro ;
Mori, Kazushige ;
Tanaka, Yutaka .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (06) :795-805